Bristol-Myers Subpoenaed Over Plavix Deal

Law360, New York (April 3, 2007, 12:00 AM EDT) -- U.S. antitrust regulators have sent a subpoena to Bristol-Myers Squibb Co. seeking information about a deal the drug maker made with generics rival Apotex Inc. to delay competition for its popular blood-thinner Plavix.

The request for information from the U.S. Federal Trade Commission was revealed on March 21 in Bristol-Myers Squibb’s annual regulatory filing with the U.S. Securities and Exchange Commission.

The New York-based company said in a statement that it plans to cooperate fully with the investigation. The deal at the center of the probe...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.